Citations (131)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
João Mauricio Castaldelli-Maia, Victoria Camargos de Oliveira, Flávia Mariana Irber, Israel K. Blaas, Bernard Angerville, Anderson Sousa Martins-da-Silva, Gislaine Koch Gimenes, Marcela Waisman Campos, Julio Torales, Antonio Ventriglio, Carine Guillois, Houria El Ouazzani, Léna Gazaix, Pascal Favré, Alain Dervaux & Gisèle Apter. (2023) Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders. International Review of Psychiatry 0:0, pages 1-21.
Read now
Read now
Sunil Dutt & Vikas Tyagi. (2023) Synthesis and substrate-controlled modification of β-aminocarbonyl using α-amylase enzyme and Pd-catalyst in one-pot. Biocatalysis and Biotransformation 0:0, pages 1-11.
Read now
Read now
Giulio Perugi, Ugo De Rosa & Margherita Barbuti. (2022) What value do norepinephrine/dopamine dual reuptake inhibitors have to the current treatment of adult attention deficit hyperactivity disorder (ADHD) treatment armamentarium?. Expert Opinion on Pharmacotherapy 23:18, pages 1975-1978.
Read now
Read now
Kenneth Blum, Bruce Steinberg, Marjorie C Gondre-Lewis, David Baron, Edward J Modestino, Rajendra D Badgaiyan, B William Downs, Debasis Bagchi, Raymond Brewer, Thomas McLaughlin, Abdalla Bowirrat & Mark Gold. (2021) A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing “Precision Behavioral Management”. Psychology Research and Behavior Management 14, pages 2115-2134.
Read now
Read now
Sandipan Bhattacharjee, Jeannie K Lee, Nina Vadiei, Asad E Patanwala, Daniel C Malone, Shannon M Knapp, Wei-Hsuan Lo-Ciganic & William J Burke. (2020) Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder. Neuropsychiatric Disease and Treatment 16, pages 1433-1450.
Read now
Read now
Steve Offerman, Jasmin Gosen, Stephen H. Thomas, Angie Padilla-Jones, Anne-Michelle Ruha & Michael Levine. (2020) Bupropion associated seizures following acute overdose: who develops late seizures. Clinical Toxicology 58:12, pages 1306-1312.
Read now
Read now
Ariana M. Chao, Thomas A. Wadden, Robert I. Berkowitz, Kerry Quigley & Frank Silvestry. (2020) The risk of cardiovascular complications with current obesity drugs. Expert Opinion on Drug Safety 19:9, pages 1095-1104.
Read now
Read now
Rafaela Costa, Nuno G. Oliveira & Ricardo Jorge Dinis-Oliveira. (2019) Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects. Drug Metabolism Reviews 51:3, pages 293-313.
Read now
Read now
Ranjeet Prasad Dash, Rana Rais & Nuggehally R. Srinivas. (2018) Chirality and neuropsychiatric drugs: an update on stereoselective disposition and clinical pharmacokinetics of bupropion. Xenobiotica 48:9, pages 945-957.
Read now
Read now
Tariq Chukir, Alpana P. Shukla, Katherine H. Saunders & Louis J. Aronne. (2018) Pharmacotherapy for obesity in individuals with type 2 diabetes. Expert Opinion on Pharmacotherapy 19:3, pages 223-231.
Read now
Read now
David B. Liss, Todd M. Phillips, Anthony F. Pizon & Evan S. Schwarz. (2017) Delayed seizures in bupropion overdose with concomitant ingestion of alpha-2 agonist: a case report. Toxicology Communications 1:1, pages 15-17.
Read now
Read now
Felix-Martin Werner & Rafael Coveñas. (2010) Classical Neurotransmitters and Neuropeptides Involved in Major Depression: a Review. International Journal of Neuroscience 120:7, pages 455-470.
Read now
Read now
H.-P. Lei, X.-Y. Yu, H.-T. Xie, H.-H. Li, L. Fan, L.-L. Dai, Y. Chen & H.-H. Zhou. (2010) Effect of St. John’s wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers. Xenobiotica 40:4, pages 275-281.
Read now
Read now
Angela J. Grippo & Alan Kim Johnson. (2009) Stress, depression and cardiovascular dysregulation: A review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 12:1, pages 1-21.
Read now
Read now
Victor Maridakis, Patrick J. O'Connor & Phillip D. Tomporowski. (2009) Sensitivity to Change in Cognitive Performance and Mood Measures of Energy and Fatigue in Response to Morning Caffeine Alone or in Combination With Carbohydrate. International Journal of Neuroscience 119:8, pages 1239-1258.
Read now
Read now
James W Jefferson. (2008) Bupropion extended-release for depressive disorders. Expert Review of Neurotherapeutics 8:5, pages 715-722.
Read now
Read now
Sarah M. R. Wille, Sarah G. Cooreman, Hugo M. Neels & Willy E. E. Lambert. (2008) Relevant Issues in the Monitoring and the Toxicology of Antidepressants. Critical Reviews in Clinical Laboratory Sciences 45:1, pages 25-89.
Read now
Read now
Chi-Un Pae, Hyun-Kook Lim, Changsu Han, Ashwin A Patkar, David C Steffens, Prakash S Masand & Chul Lee. (2007) Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion. Expert Review of Neurotherapeutics 7:10, pages 1251-1263.
Read now
Read now
Articles from other publishers (113)
Malik Alwindi & Ariege Bizanti. (2023) Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions. Heliyon 9:11, pages e22413.
Crossref
Crossref
Zhenxiang Gao, T. John Winhusen, Maria Gorenflo, Udi E. Ghitza, Edward Nunes, Andrew J. Saxon, Todd Korthuis, Kathleen Brady, Sean Luo, Pamela B. Davis, David C. Kaelber & Rong Xu. (2023) Potential effect of antidepressants on remission from cocaine use disorder – A nationwide matched retrospective cohort study. Drug and Alcohol Dependence 251, pages 110958.
Crossref
Crossref
Austin Clark, Brendan Tate, Bretton Urban, Ryan Schroeder, Sonja Gennuso, Shahab Ahmadzadeh, David McGregor, Brook Girma, Sahar Shekoohi & Alan D. Kaye. (2023) Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation. Health Psychology Research 11.
Crossref
Crossref
Ryo Okuyama. (2023) Advancements in Drug Repurposing: Examples in Psychiatric Medications. International Journal of Molecular Sciences 24:13, pages 11000.
Crossref
Crossref
Daanish Y Khan, Bita C Behaeddin, Stepan Uhlyar & Jonathan M Parker. (2023) Bupropion Treatment for Stimulant Withdrawal in a Patient With Substance Use Disorder and Unspecified Bipolar Disorder. Cureus.
Crossref
Crossref
K. Dobšíková, Ž. Javorská, M. Paškan, D. Spálovská, P. Trembulaková, J. Herciková, M. Kuchař, V. Kozmík, M. Kohout & V. Setnička. (2023) Enantioseparation and a comprehensive spectroscopic analysis of novel synthetic cathinones laterally substituted with a trifluoromethyl group. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 291, pages 122320.
Crossref
Crossref
Marcin Kosmalski, Kacper Deska, Bartłomiej Bąk, Monika Różycka-Kosmalska & Tadeusz Pietras. (2023) Pharmacological Support for the Treatment of Obesity—Present and Future. Healthcare 11:3, pages 433.
Crossref
Crossref
Fedor I. Zubkov & Vladimir V. Kouznetsov. (2023) Traveling across Life Sciences with Acetophenone—A Simple Ketone That Has Special Multipurpose Missions. Molecules 28:1, pages 370.
Crossref
Crossref
Nadia O Bamfo, Jessica BL Lu & Zeruesenay Desta. (2023) Stereoselective Metabolism of Bupropion to Active Metabolites in Cellular Fractions of Human Liver and Intestine. Drug Metabolism and Disposition 51:1, pages 54-66.
Crossref
Crossref
Paul El Meouchy, Mohamad Wahoud, Sabine Allam, Roy Chedid, Wissam Karam & Sabine Karam. (2022) Hypertension Related to Obesity: Pathogenesis, Characteristics and Factors for Control. International Journal of Molecular Sciences 23:20, pages 12305.
Crossref
Crossref
Leah A. Johnston, Raed Alhusayen, Marc Bourcier, Isabelle Delorme, Ralph George, Elizabeth O’Brien, Se Mang Wong & Susan M. Poelman. (2022) Practical Guidelines for Managing Patients With Hidradenitis Suppurativa: An Update. Journal of Cutaneous Medicine and Surgery 26:2_suppl, pages 2S-24S.
Crossref
Crossref
Nini de Boer & Wiepke Cahn. (2022) Antipsychotic‐induced weight gain: Is the weight over? New guidelines needed. Acta Psychiatrica Scandinavica 146:3, pages 185-189.
Crossref
Crossref
Deepan Singh, Emily Mozdzer & Aaron Pinkhasov. 2022. Neuro-behavioral Manifestations of Prader-Willi Syndrome. Neuro-behavioral Manifestations of Prader-Willi Syndrome
116
144
.
Haley N. Phillips & Laura Tormoehlen. (2022) Toxin-Induced Seizures ∗Adapted from “Toxin-Induced Seizures” in Neurologic Clinics, November 2020. Emergency Medicine Clinics of North America 40:2, pages 417-430.
Crossref
Crossref
Ariana M. Chao, Kerry M. Quigley & Thomas A. Wadden. 2022. Clinical Obesity in Adults and Children. Clinical Obesity in Adults and Children
249
261
.
Sarah Rushdi Khunfur, Reem Ebraheem Aldaheri, Faisal Hadid M Aljuaid, Abdulghani Husain Ali Seddiqa, Gaida Mohammadamen B Felemban, Abdulrahman Ahmed Hadadi, Nawaf Abdulmohsen Al-Kuait, Moath Sulieman Aljabri, Bdulaziz Musaad Aldayel & Hamdan Ayed Hamdan Albathali. (2022) Smoking Cessation Interventions in Primary Healthcare Settings. International Journal Of Pharmaceutical Research And Allied Sciences 11:1, pages 21-28.
Crossref
Crossref
João V. S. Guerra, Marieli M. G. Dias, Anna J. V. C. Brilhante, Maiara F. Terra, Marta García-Arévalo & Ana Carolina M. Figueira. (2021) Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases. Nutrients 13:8, pages 2830.
Crossref
Crossref
Angeliki Siamidi, Aikaterini Dedeloudi & Marilena Vlachou. (2021) Probing the Release of Bupropion and Naltrexone Hydrochloride Salts from Biopolymeric Matrices of Diverse Chemical Structures. Polymers 13:9, pages 1456.
Crossref
Crossref
Brian P. Murray, Joseph E. Carpenter, Joshua Sayers, Michael Yeh, Jordan Beau, Emily A. Kiernan, Matthew J. Wolf, Tonya A. Bolton & Ziad Kazzi. (2021) Two Cases of Serotonin Syndrome After Bupropion Overdose Treated With Cyproheptadine. The Journal of Emergency Medicine 60:4, pages e67-e71.
Crossref
Crossref
Sana Tafseer, Rachna Gupta, Rafat Ahmad, Seema Jain, M.S. Bhatia & Lalit K. Gupta. (2021) Bupropion monotherapy alters neurotrophic and inflammatory markers in patients of major depressive disorder. Pharmacology Biochemistry and Behavior 200, pages 173073.
Crossref
Crossref
Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide
117
122
.
Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide.
Haley N. Phillips & Laura Tormoehlen. (2020) Toxin-Induced Seizures. Neurologic Clinics 38:4, pages 867-879.
Crossref
Crossref
Amir Rashidian, Pegah Dejban, Kiana Karami Fard, Alireza Abdollahi, Mohsen Chamanara, Ahmadreza Dehpour & Amin Hasanvand. (2020) Bupropion Ameliorates Acetic Acid–Induced Colitis in Rat: the Involvement of the TLR4/NF-kB Signaling Pathway. Inflammation 43:5, pages 1999-2009.
Crossref
Crossref
José Manuel Lerma-Cabrera, Francisca Carvajal, James C. Garbutt, Montserrat Navarro & Todd E. Thiele. (2020) The melanocortin system as a potential target for treating alcohol use disorders: A review of pre-clinical data. Brain Research 1730, pages 146628.
Crossref
Crossref
Kaipuzha Venu Athira, Sikta Bandopadhyay, Pavan Kumar Samudrala, V.G.M. Naidu, Mangala Lahkar & Sumana Chakravarty. (2020) An Overview of the Heterogeneity of Major Depressive Disorder: Current Knowledge and Future Prospective. Current Neuropharmacology 18:3, pages 168-187.
Crossref
Crossref
Ramon R. ContrucciTibor M. Brunt, Funda InanEric J. F. FranssenLaura Hondebrink. (2020) Synthetic Cathinones and Their Potential Interactions with Prescription Drugs. Therapeutic Drug Monitoring 42:1, pages 75-82.
Crossref
Crossref
Brian Murray, Joseph Carpenter, Camille Dunkley, Tim P. Moran, Emily A. Kiernan, Tony Rianprakaisang, Waleed S. Alsukaiti, Diane P. Calello & Ziad Kazzi. (2019) Single-Agent Bupropion Exposures: Clinical Characteristics and an Atypical Cause of Serotonin Toxicity. Journal of Medical Toxicology 16:1, pages 12-16.
Crossref
Crossref
Emma A. Honkanen, Nina Kemppainen, Tommi Noponen, Marko Seppänen, Juho Joutsa & Valtteri Kaasinen. (2019) Bupropion Causes Misdiagnosis in Brain Dopamine Transporter Imaging for Parkinsonism. Clinical Neuropharmacology 42:5, pages 181-183.
Crossref
Crossref
Montserrat Navarro, Kendall L. Luhn, Alexey B. Kampov‐Polevoy, James C. Garbutt & Todd E. Thiele. (2019)
Bupropion, Alone and in Combination with Naltrexone, Blunts Binge‐Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57
BL
/6J Mice
. Alcoholism: Clinical and Experimental Research 43:5, pages 783-790.
Crossref
Crossref
Gerald Gartlehner, Barbara Nussbaumer-Streit, Bradley N Gaynes, Catherine A Forneris, Laura C Morgan, Amy Greenblatt, Jörg Wipplinger, Linda J Lux, Megan G Van Noord & Dietmar Winkler. (2019) Second-generation antidepressants for preventing seasonal affective disorder in adults. Cochrane Database of Systematic Reviews 2019:4.
Crossref
Crossref
Nina Vadiei & Sandipan Bhattacharjee. (2018) Patterns and predictors of depression treatment among adults with chronic kidney disease and depression in ambulatory care settings in the United States. International Urology and Nephrology 51:2, pages 303-309.
Crossref
Crossref
Tatsuya Nagano, Masahiro Katsurada, Yuichiro Yasuda, Kazuyuki Kobayashi & Yoshihiro Nishimura. (2019) Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials. Therapeutic Advances in Respiratory Disease 13, pages 175346661987592.
Crossref
Crossref
Kanit Tha Deang, Hatta Sidi, Hazli Zakaria, Raja Lope Adam, Srijit Das, Nurul Hazwani Hatta, Muhammad Hizri Hatta & Kok Wei Wee. (2018) The Novelty of Bupropion As a Dopaminergic Antidepressant for the Treatment of Adult Attention Deficit Hyperactive Disorder. Current Drug Targets 20:2, pages 210-219.
Crossref
Crossref
Mostafa Mahmoud Hamdy, Mohamed Mostafa Elbadr & Ahmed Barakat. (2018) Bupropion attenuates morphine tolerance and dependence: Possible role of glutamate, norepinephrine, inflammation, and oxidative stress. Pharmacological Reports 70:5, pages 955-962.
Crossref
Crossref
Sergios Charntikov, Steven T. Pittenger, Cindy M. Pudiak & Rick A. Bevins. (2018) The effect of N-acetylcysteine or bupropion on methamphetamine self-administration and methamphetamine–triggered reinstatement of female rats. Neuropharmacology 135, pages 487-495.
Crossref
Crossref
Candida J. Rebello, Elena V. Nikonova, Sharon Zhou, Louis J. Aronne, Ken Fujioka, W. Timothy Garvey, Steven R. Smith, Ann A. Coulter & Frank L. Greenway. (2018) Effect of Lorcaserin Alone and in Combination with Phentermine on Food Cravings After 12-Week Treatment: A Randomized Substudy. Obesity 26:2, pages 332-339.
Crossref
Crossref
John R. Richards, Jessica B. Gould, Erik G. Laurin & Timothy E. Albertson. (2018) Metoprolol treatment of dual cocaine and bupropion cardiovascular and central nervous system toxicity. Clinical and Experimental Emergency Medicine 6:1, pages 84-88.
Crossref
Crossref
Justin C. Strickland & William W. Stoops. 2018. Adolescent Substance Abuse. Adolescent Substance Abuse
233
260
.
David Benaiges, Juan Pedro-Botet, Juana A. Flores-Le Roux, Elisenda Climent & Albert Goday. (2017) Pasado, presente y futuro de la farmacoterapia para la obesidad. Clínica e Investigación en Arteriosclerosis 29:6, pages 256-264.
Crossref
Crossref
David Benaiges, Juan Pedro-Botet, Juana A. Flores-Le Roux, Elisenda Climent & Albert Goday. (2017) Past, present and future of pharmacotherapy for obesity. Clínica e Investigación en Arteriosclerosis (English Edition) 29:6, pages 256-264.
Crossref
Crossref
Jamie N. Connarn, Stephanie Flowers, Marisa Kelly, Ruijuan Luo, Kristen M. Ward, Gloria Harrington, Ila Moncion, Masoud Kamali, Melivin McInnis, Meihua R. Feng, Vicki Ellingrod, Andrew Babiskin, Xinyuan Zhang & Duxin Sun. (2017) Pharmacokinetics and Pharmacogenomics of Bupropion in Three Different Formulations with Different Release Kinetics in Healthy Human Volunteers. The AAPS Journal 19:5, pages 1513-1522.
Crossref
Crossref
J.J. Rasimas & Courtney M. Sinclair. (2017) Assessment and Management of Toxidromes in the Critical Care Unit. Critical Care Clinics 33:3, pages 521-541.
Crossref
Crossref
Yu Kawai, Andrea G. DeMonbrun, Rebecca S. Chambers, Danielle A. NolanBram A. Dolcourt, Nasuh M. Malas & Michael W. Quasney. (2017) A Previously Healthy Adolescent With Acute Encephalopathy and Decorticate Posturing. Pediatrics 139:1.
Crossref
Crossref
J. van Enkhuizen & J.W. Young. 2017. Negative Affective States and Cognitive Impairments in Nicotine Dependence. Negative Affective States and Cognitive Impairments in Nicotine Dependence
21
36
.
Hai-yin Jiang, Lian-lian Xu, Yu-cuan Li, Min Deng, Chun-ting Peng & Bing Ruan. (2016) Antidepressant use during pregnancy and risk of postpartum hemorrhage: A systematic review and meta-analysis. Journal of Psychiatric Research 83, pages 160-167.
Crossref
Crossref
LE Grzeskowiak, R McBain, GA Dekker & VL Clifton. (2016) Antidepressant use in late gestation and risk of postpartum haemorrhage: a retrospective cohort study. BJOG: An International Journal of Obstetrics & Gynaecology 123:12, pages 1929-1936.
Crossref
Crossref
Candida J. Rebello & Frank L. Greenway. (2016) Reward-Induced Eating: Therapeutic Approaches to Addressing Food Cravings. Advances in Therapy 33:11, pages 1853-1866.
Crossref
Crossref
Elizabeth A. Cabrera, Corinde E. Wiers, Elsa Lindgren, Gregg Miller, Nora D. Volkow & Gene-Jack Wang. (2016) Neuroimaging the Effectiveness of Substance Use Disorder Treatments. Journal of Neuroimmune Pharmacology 11:3, pages 408-433.
Crossref
Crossref
Alexander K.C. Leung & Kam Lun Hon. (2016) Attention-Deficit/Hyperactivity Disorder. Advances in Pediatrics 63:1, pages 255-280.
Crossref
Crossref
Larissa J. Mooney, Maureen P. Hillhouse, Christie Thomas, Alfonso Ang, Gaurav Sharma, Garth Terry, Linda Chang, Robrina Walker, Madhukar Trivedi, David Croteau, Steven Sparenborg & Walter Ling. (2016) Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder. Journal of Addiction Medicine 10:4, pages 236-243.
Crossref
Crossref
Michael D. Leitl & S. Stevens Negus. (2016) Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and ∆9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats. Behavioural Pharmacology 27:4, pages 364-376.
Crossref
Crossref
S.R. Khan, R.T. Berendt, C.D. Ellison, A.B. Ciavarella, E. Asafu-Adjaye, M.A. Khan & P.J. Faustino. 2016.
1
30
.
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
111
143
.
Gerald Gartlehner, Barbara Nussbaumer, Bradley N Gaynes, Catherine A Forneris, Laura C Morgan, Angela Kaminski-Hartenthaler, Amy Greenblatt, Jörg Wipplinger, Linda J Lux, Jeffrey H Sonis, Julia Hofmann, Megan G Van Noord & Dietmar Winkler. (2015) Second-generation antidepressants for preventing seasonal affective disorder in adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Mark J. Millan, Guy M. Goodwin, Andreas Meyer-Lindenberg & Sven Ove Ögren. (2015) Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders. European Neuropsychopharmacology 25:5, pages 599-656.
Crossref
Crossref
Gyula Bokor & Peter D. Anderson. (2014) Attention-Deficit/Hyperactivity Disorder. Journal of Pharmacy Practice 27:4, pages 336-349.
Crossref
Crossref
Sonja K. Billes, Puspha Sinnayah & Michael A. Cowley. (2014) Naltrexone/bupropion for obesity: An investigational combination pharmacotherapy for weight loss. Pharmacological Research 84, pages 1-11.
Crossref
Crossref
Mai Ahmed, Wesam M El-Bakly, Ahmed M Zaki, Lobna F abd Alzez & Osama El serafi. (2014) Bupropion effects on high-fat diet-induced steatohepatitis and endothelial dysfunction in rats: role of tumour necrosis factor-alpha. Journal of Pharmacy and Pharmacology 66:6, pages 793-801.
Crossref
Crossref
G-J Wang, D Tomasi, N D Volkow, R Wang, F Telang, E C Caparelli & E Dunayevich. (2013) Effect of combined naltrexone and bupropion therapy on the brain’s reactivity to food cues. International Journal of Obesity 38:5, pages 682-688.
Crossref
Crossref
Lucie Skarydova, Radana Tomanova, Lucie Havlikova, Hana Stambergova, Petr Solich & Vladimir Wsol. (2014) Deeper Insight into the Reducing Biotransformation of Bupropion in the Human Liver. Drug Metabolism and Pharmacokinetics 29:2, pages 177-184.
Crossref
Crossref
Caroline T. Nguyen, Michael I. MacEntee, Barbara Mintzes & Thomas L. Perry. (2013) Information for Physicians and Pharmacists About Drugs That Might Cause Dry Mouth: A Study of Monographs and Published Literature. Drugs & Aging 31:1, pages 55-65.
Crossref
Crossref
Priscilla Hollander, Alok K. Gupta, Raymond Plodkowski, Frank Greenway, Harold Bays, Colleen Burns, Preston Klassen & Ken Fujioka. (2013) Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes. Diabetes Care 36:12, pages 4022-4029.
Crossref
Crossref
Baljit KhambaMonique AucoinMillie LytleMonica VermaniAnabel MaldonadoChristina IorioCatherine CameronDina TsirgielisChristina D'AmbrosioLeena AnandMartin A. Katzman. (2013) Efficacy of Acupuncture Treatment of Sexual Dysfunction Secondary to Antidepressants. The Journal of Alternative and Complementary Medicine 19:11, pages 862-869.
Crossref
Crossref
Gian Marco Leggio, Salvatore Salomone, Claudio Bucolo, Chiara Platania, Vincenzo Micale, Filippo Caraci & Filippo Drago. (2013) Dopamine D3 receptor as a new pharmacological target for the treatment of depression. European Journal of Pharmacology 719:1-3, pages 25-33.
Crossref
Crossref
C.R. Cámara-Lemarroy, F.J. Guzmán-de la Garza, P. Cordero-Pérez, G. Alarcón-Galván, J.M. Ibarra-Hernández, L.E. Muñoz-Espinosa & N.E. Fernández-Garza. (2013) Bupropion Reduces the Inflammatory Response and Intestinal Injury Due to Ischemia-Reperfusion. Transplantation Proceedings 45:6, pages 2502-2505.
Crossref
Crossref
Geila Ribeiro Nuñez, Hélio Pinczowski, Rebecca Zanellato, Lívia Tateyama, Fernanda Schindler, Fernando Fonseca & Auro del Giglio. (2013) Bupropion for Control of Hot Flashes in Breast Cancer Survivors: A Prospective, Double-Blind, Randomized, Crossover, Pilot Phase II Trial. Journal of Pain and Symptom Management 45:6, pages 969-979.
Crossref
Crossref
MATTHEW BRENSILVER, KEITH G. HEINZERLING, AIMEE‐NOELLE SWANSON, DONATELLO TELESCA, BENJAMIN A. FURST & STEVEN J. SHOPTAW. (2012) Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment. Drug and Alcohol Review 32:1, pages 96-99.
Crossref
Crossref
Jason R. Clapper, Jennifer Athanacio, Carrie Wittmer, Pete S. Griffin, Lawrence D'Souza, David G. Parkes & Jonathan D. Roth. (2013) Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models. European Journal of Pharmacology 698:1-3, pages 292-298.
Crossref
Crossref
Ross J. BaldessariniRoss J. Baldessarini. 2013. Chemotherapy in Psychiatry. Chemotherapy in Psychiatry
155
250
.
Chitra Sridar, Cesar Kenaan & Paul F. Hollenberg. (2012) Inhibition of Bupropion Metabolism by Selegiline: Mechanism-Based Inactivation of Human CYP2B6 and Characterization of Glutathione and Peptide Adducts. Drug Metabolism and Disposition 40:12, pages 2256-2266.
Crossref
Crossref
Matthew W. Hedge. (2012) Miscellaneous Central Nervous System Intoxicants. Critical Care Clinics 28:4, pages 587-600.
Crossref
Crossref
John J. Mariani & Frances R. Levin. (2012) Psychostimulant Treatment of Cocaine Dependence. Psychiatric Clinics of North America 35:2, pages 425-439.
Crossref
Crossref
Jorge L. Sepulveda. 2012. Pharmacogenomics in Clinical Therapeutics. Pharmacogenomics in Clinical Therapeutics
144
175
.
Tammy J. LindsayKirsten VitrikasMichael TemporalChristopher M. Herndon. (2012) Diabetic Neuropathic Pain: Real World Treatment Options. Clinical Medicine Insights: Therapeutics 4, pages CMT.S7266.
Crossref
Crossref
Gregory L. Holmes. 2012. Swaiman's Pediatric Neurology. Swaiman's Pediatric Neurology
736
750
.
S. Porcelli, A. Drago, C. Fabbri & A. Serretti. (2011) Mechanisms of antidepressant action: An integrated dopaminergic perspective. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:7, pages 1532-1543.
Crossref
Crossref
Ibrahim A. Abdel-Hamid & El-Sayed Saleh. (2011) Primary Lifelong Delayed Ejaculation: Characteristics and Response to Bupropion. The Journal of Sexual Medicine 8:6, pages 1772-1779.
Crossref
Crossref
Trine Flensborg-Madsen, Mikael Bay von Scholten, Esben Meulengracht Flachs, Erik Lykke Mortensen, Eva Prescott & Janne Schurmann Tolstrup. (2011) Tobacco smoking as a risk factor for depression. A 26-year population-based follow-up study. Journal of Psychiatric Research 45:2, pages 143-149.
Crossref
Crossref
T. Javelot, H. Javelot, A. Baratta, L. Weiner, M. Messaoudi & P. Lemoine. (2010) Troubles psychotiques aigus liés au bupropion : revue de la littérature. L'Encéphale 36:6, pages 461-471.
Crossref
Crossref
Arthur L. Brody, Edythe D. London, Richard E. Olmstead, Zoe Allen-Martinez, Stephanie Shulenberger, Matthew R. Costello, Anna L. Abrams, David Scheibal, Judah Farahi, Steven Shoptaw & Mark A. Mandelkern. (2010) Smoking-induced change in intrasynaptic dopamine concentration: Effect of treatment for Tobacco Dependence. Psychiatry Research: Neuroimaging 183:3, pages 218-224.
Crossref
Crossref
Nehad A. El-Sayed, Fadi M. Awadallah, Nashwa A. Ibrahim & Mohammed T. El-Saadi. (2010) Synthesis, anti-inflammatory and ulcerogenicity studies of some substituted pyrimido[1,6-a]azepine derivatives. European Journal of Medicinal Chemistry 45:7, pages 3147-3154.
Crossref
Crossref
Mustafa A. Mufti, Paul E. HoltzheimerIIIIII, Charles M. Epstein, Sinéad C. Quinn, Nancie Vito & William M. McDonald. (2010) Bupropion decreases resting motor threshold: A case report. Brain Stimulation 3:3, pages 177-180.
Crossref
Crossref
KA BrennanRA Lea, PS Fitzmaurice & P. Truman. (2009) Review: Nicotinic receptors and stages of nicotine dependence. Journal of Psychopharmacology 24:6, pages 793-808.
Crossref
Crossref
Agnieszka Krzyżosiak, Monika Szyszka-Niagolov, Marta Wietrzych, Serge Gobaille, Shin-ichi Muramatsu & Wojciech Krężel. (2010) Retinoid X Receptor Gamma Control of Affective Behaviors Involves Dopaminergic Signaling in Mice. Neuron 66:6, pages 908-920.
Crossref
Crossref
Elizabeth L. Thorpe, Anthony F. Pizon, Michael J. Lynch & Jessica Boyer. (2010) Bupropion Induced Serotonin Syndrome: A Case Report. Journal of Medical Toxicology 6:2, pages 168-171.
Crossref
Crossref
Bárbara Tagliari, Cristie G. Noschang, Andréia G. K. Ferreira, Otávio A. Ferrari, Luciane R. Feksa, Clovis M. D. Wannmacher, Carla Dalmaz & Angela T. S. Wyse. (2010) Chronic variable stress impairs energy metabolism in prefrontal cortex and hippocampus of rats: prevention by chronic antioxidant treatment. Metabolic Brain Disease 25:2, pages 169-176.
Crossref
Crossref
S. I. Woodruff, T. L. Conway, A. M. Shillington, J. D. Clapp, H. Lemus & M. B. Reed. (2010) Cigarette smoking and subsequent hospitalization in a cohort of young U.S. Navy female recruits. Nicotine & Tobacco Research 12:4, pages 365-373.
Crossref
Crossref
Cassidy VuongStan H. M. Van UumLaura E. O'DellKabirullah Lutfy & Theodore C. Friedman. (2010) The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems. Endocrine Reviews 31:1, pages 98-132.
Crossref
Crossref
Marco Cosentino, Franca Marino & Sergio Lecchini. (2009) Resistance of naturally occurring regulatory T cells toward oxidative stress: possible link with intracellular catecholamine content and implications for cancer therapy. Blood 114:2, pages 487-488.
Crossref
Crossref
Frank L. Greenway, M.J. Whitehouse, Maria Guttadauria, James W. Anderson, Richard L. Atkinson, Ken Fujioka, Kishore M. Gadde, Alok K. Gupta, Patrick O'Neil, Donald Schumacher, Diane Smith, Eduardo Dunayevich, Gary D. Tollefson, Eckard Weber & Michael A. Cowley. (2012) Rational Design of a Combination Medication for the Treatment of Obesity. Obesity 17:1, pages 30-39.
Crossref
Crossref
M.E. Breuer, J.S.W. Chan, R.S. Oosting, L. Groenink, S.M. Korte, U. Campbell, R. Schreiber, T. Hanania, E.M.S. Snoeren, M. Waldinger & B. Olivier. (2008) The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects. European Neuropsychopharmacology 18:12, pages 908-916.
Crossref
Crossref
S. R. Hansson, B. Bottalico, V. Noskova & B. Casslen. (2008) Monoamine transporters in human endometrium and decidua. Human Reproduction Update 15:2, pages 249-260.
Crossref
Crossref
Julie A. Pasco, Lana J. Williams, Felice N. Jacka, Felicity Ng, Margaret J. Henry, Geoffrey C. Nicholson, Mark A. Kotowicz & Michael Berk. (2018) Tobacco smoking as a risk factor for major depressive disorder: population-based study. British Journal of Psychiatry 193:4, pages 322-326.
Crossref
Crossref
Carmen Gómez, Carmen Carrasco & Rosa Redolat. (2008) PRECLINICAL STUDY: Effects of bupropion, alone or coadministered with nicotine, on social behavior in mice. Addiction Biology 13:3-4, pages 301-309.
Crossref
Crossref
Sonja K Billes & Michael A Cowley. (2007) Catecholamine Reuptake Inhibition Causes Weight Loss by Increasing Locomotor Activity and Thermogenesis. Neuropsychopharmacology 33:6, pages 1287-1297.
Crossref
Crossref
Matthew J. Winter, William S. Redfern, Amanda J. Hayfield, Stewart F. Owen, Jean-Pierre Valentin & Thomas H. Hutchinson. (2008) Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. Journal of Pharmacological and Toxicological Methods 57:3, pages 176-187.
Crossref
Crossref
Johnny S.W. Chan, Berend Olivier, Trynke R. de Jong, Eelke M.S. Snoeren, Elke Kooijman, Felisa N. van Hasselt, Jules H.W. Limpens, Martien J.H. Kas, Marcel D. Waldinger & Ronald S. Oosting. (2008) Translational research into sexual disorders: Pharmacology and genomics. European Journal of Pharmacology 585:2-3, pages 426-435.
Crossref
Crossref
Michael E. ThaseTimothey Denko. (2008) Pharmacotherapy of Mood Disorders. Annual Review of Clinical Psychology 4:1, pages 53-91.
Crossref
Crossref
Andrew A. Nierenberg, Michael J. Ostacher, Jeffrey C. Huffman, Rebecca M. Ametrano, Maurizio Fava & Roy H. Perlis. (2008) A Brief Review of Antidepressant Efficacy, Effectiveness, Indications, and Usage for Major Depressive Disorder. Journal of Occupational & Environmental Medicine 50:4, pages 428-436.
Crossref
Crossref
Gian Marco Leggio, Vincenzo Micale & Filippo Drago. (2008) Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST). European Neuropsychopharmacology 18:4, pages 271-277.
Crossref
Crossref
Alcy R. Torres, Jane Whitney & Joseph Gonzalez-Heydrich. (2008) Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: Review of pharmacological treatment. Epilepsy & Behavior 12:2, pages 217-233.
Crossref
Crossref
Johnny Graham & David Coghill. (2008) Adverse Effects of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder. CNS Drugs 22:3, pages 213-237.
Crossref
Crossref
Yann Le Strat, Nicolas Ramoz, Paul Pickering, Virginie Burger, Claudette Boni, Henri-Jean Aubin, Jean Adès, Philippe Batel & Philip Gorwood. (2007) The 3′ Part of the Dopamine Transporter Gene DAT1/SLC6A3 Is Associated With Withdrawal Seizures in Patients With Alcohol Dependence. Alcoholism: Clinical and Experimental Research 32:1, pages 27-35.
Crossref
Crossref
Xiangmin Li, Ming Zhao, Yu-Rong Tang, Chao Wang, Ziding Zhang & Shiqi Peng. (2008) N-[2-(5,5-Dimethyl-1,3-dioxane-2-yl)ethyl]amino acids: Their synthesis, anti-inflammatory evaluation and QSAR analysis. European Journal of Medicinal Chemistry 43:1, pages 8-18.
Crossref
Crossref
Scott D. Mendelson. 2008. Metabolic Syndrome and Psychiatric Illness. Metabolic Syndrome and Psychiatric Illness
73
91
.
James C. Milton & Aza Abdulla. (2007) Prolonged oro-facial dystonia in a 58 year old female following therapy with bupropion and St John's Wort. British Journal of Clinical Pharmacology 64:5, pages 717-718.
Crossref
Crossref
Antoine Makhlouf, Ashay Kparker & Craig S. Niederberger. (2007) Depression and Erectile Dysfunction. Urologic Clinics of North America 34:4, pages 565-574.
Crossref
Crossref
Michael Miovic & Susan Block. (2007) Psychiatric disorders in advanced cancer. Cancer 110:8, pages 1665-1676.
Crossref
Crossref
Hassan H. López, Gabriel Wurzel & Benjamin Ragen. (2007) The effect of acute bupropion on sexual motivation and behavior in the female rat. Pharmacology Biochemistry and Behavior 87:3, pages 369-379.
Crossref
Crossref
Ulrich M Zanger, Kathrin Klein, Tanja Saussele, Julia Blievernicht, Marco H Hofmann & Matthias Schwab. (2007)
Polymorphic
CYP2B6
: molecular mechanisms and emerging clinical significance
. Pharmacogenomics 8:7, pages 743-759.
Crossref
Crossref
Kevin P DeSanty & Celene M Amabile. (2016) Antidepressant-lnduced Liver Injury. Annals of Pharmacotherapy 41:7-8, pages 1201-1211.
Crossref
Crossref
Shuang Liu & Bruce F. Molino. 2007. Annual Reports in Medicinal Chemistry Volume 42. Annual Reports in Medicinal Chemistry Volume 42
13
26
.